InvestLog
KYMR logo

KYMR

Kymera Therapeutics, Inc.NASDAQHealthcare
$85.40+0.55%ClosedMarket Cap: $6.97B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-03UBS—Buy—
2026-03-02Citigroup—Buy—
2026-03-02Stephens & Co.—Overweight—
2026-02-26BTIG—Buy—
2026-02-26Piper Sandler—Overweight—
2026-01-28Barclays—Overweight—
2026-01-15BTIG—Buy—
2026-01-06Wolfe Research—Peer Perform—
2025-12-22B. Riley Securities—Buy—
2025-12-16RBC Capital—Outperform—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-4.16$43.1M15
Sun Dec 31$-4.12$43.2M14
Mon Dec 31$-4.39$54.1M8
Tue Dec 31$-3.32$222.2M12